: Global recommendations advocate the conditional use of donor human milk (DHM), yet evidence on the influence of donor characteristics and DHM treatment on premature infants' health and growth is lacking. This study aimed to compare clinical outcomes of infants fed standard DHM compared with modified DHM-based on predefined variations. We performed a systematic review searching 14 databases alongside clinical trial registries, up to 8 March, 2024. Any study designs, but case or animal studies, conference proceedings, reviews, and gray literature were included. Findings were synthesized narratively and in tables. Of 14,979 screened studies, 14 met inclusion criteria comparing clinical effects of DHM from mothers who gave birth prematurely compared with at term, DHM that was treated with high-temperature pasteurization methods compared with standard holder pasteurization, and concentrated or homogenized DHM compared with standard DHM. Our analysis revealed a significant paucity of clinical data for several interventions and a complete lack of evidence for most of our research questions, indicating insufficient evidence to support the clinical use and efficacy of the aforementioned interventions. We found substantial evidence gaps in understanding how DHM treatments influence health and growth in premature infants. Research prioritizing clinical outcomes is essential to guide milk-banking policies. The protocol was registered on PROSPERO as CRD42024522015.

A Systematic Review on the Impact of Donor Characteristics and Donor Milk Handling on Infant Health and Growth

Giribaldi M.
;
Cavallarin L.;
2026

Abstract

: Global recommendations advocate the conditional use of donor human milk (DHM), yet evidence on the influence of donor characteristics and DHM treatment on premature infants' health and growth is lacking. This study aimed to compare clinical outcomes of infants fed standard DHM compared with modified DHM-based on predefined variations. We performed a systematic review searching 14 databases alongside clinical trial registries, up to 8 March, 2024. Any study designs, but case or animal studies, conference proceedings, reviews, and gray literature were included. Findings were synthesized narratively and in tables. Of 14,979 screened studies, 14 met inclusion criteria comparing clinical effects of DHM from mothers who gave birth prematurely compared with at term, DHM that was treated with high-temperature pasteurization methods compared with standard holder pasteurization, and concentrated or homogenized DHM compared with standard DHM. Our analysis revealed a significant paucity of clinical data for several interventions and a complete lack of evidence for most of our research questions, indicating insufficient evidence to support the clinical use and efficacy of the aforementioned interventions. We found substantial evidence gaps in understanding how DHM treatments influence health and growth in premature infants. Research prioritizing clinical outcomes is essential to guide milk-banking policies. The protocol was registered on PROSPERO as CRD42024522015.
2026
Istituto di Scienze delle Produzioni Alimentari - ISPA - Sede Secondaria di Torino
donor human milk
growth
infant
nutrition
outcome
systematic review
File in questo prodotto:
File Dimensione Formato  
main.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.87 MB
Formato Adobe PDF
1.87 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/604604
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact